On Biostatistics and Clinical Trials

CQ's web blog on the issues in biostatistics and clinical trials.

Sunday, August 30, 2009

SAS IQ and OQ

›
I am not sure how many people really know these abbreviations: DOE, IQ, OQ, PQ, PV. These are the terms used in the validation of a software...
4 comments:
Sunday, August 23, 2009

Hochberg procedure for adjustment for multiplicity - an illustration

›
In a May article, I discussed several practical procedures for multiple testing issue . One of the procedures is Hockberg's procedure. T...
5 comments:
Saturday, August 08, 2009

Poisson regression and zero-inflated Poisson regression

›
Poisson regression is a method to model the frequency of event counts or the event rate, such as the number of adverse events of a certain t...
2 comments:
Saturday, August 01, 2009

Epidemiology terms, but used in clinical trials

›
Some terms often used in epidemiology fields are actually pretty commonly used in clinical trials. At least for me, I first learned these te...
1 comment:
Tuesday, July 21, 2009

Some axiom quotes about statistics

›
I had a chance to listen to a seminar by Richard De Veaux in an event organized by SAS JMP for data mining. Dick is really an excellent sp...
Thursday, July 16, 2009

Dose Escalation and Modified Fabonacci Series

›
Dose-escalation is a type of clinical trial design in which the amount of the drug is increased with each cohort that is added. Each cohort ...
Saturday, July 11, 2009

Odds Ratio and Relative Risk

›
Odds Ratio (OR) and Relative Risk (RR) are two ratios often used in the epidemiology studies and the clinical trials. They are related, but ...
Sunday, July 05, 2009

The interactive voice response system

›
Interactive Voice Response (IVR) is an interactive technology that allows a computer to detect voice and keypad inputs. Its use in clinical...
5 comments:
Saturday, June 27, 2009

Spaghetti Plot

›
The first time when I used the term "Spaghetti" was for one of the pharmacokinetic studies where I would like to see the time-conc...
3 comments:
Saturday, June 20, 2009

Williams Design

›
Williams Design is a special case of orthogonal latin squares design. It is a high-crossover design and typically used in Phase I studies. D...
5 comments:

Protocol Amendment after IND

›
In clinical development, filing of IND (Investigational New Drug) is an important milestone. FDA is required by the Modernization Act to res...
Friday, June 12, 2009

Double Dummy Technique

›
Double dummy is a technique for retaining the blind when administering supplies in a clinical trial, when the two treatments cannot be made ...
15 comments:
Friday, June 05, 2009

Group t-test or Chi-square test based on the summary data

›
Sometimes, the only data we have is the summary data (mean, standard deviation, # of subjects). Can we use the summary data (instead of the ...
Saturday, May 30, 2009

Pharmacokinetics: Verify the Steady State Under Multiple Doses

›
For a multiple-dose regimen, the amount of drug in the body is said to have reached a steady state level if the amount or average concentrat...
Saturday, May 23, 2009

Statistical validation of the surrogate endpoints

›
A surrogate endpoint is intended to substitute for a clinical endpoint. A surrogate endpoint is expected to predict clinical benefit (or ha...
1 comment:
Friday, May 15, 2009

Imaging analysis in clinical trial

›
Medical imaging has now been a critical part in clinical trials. It can be used in many aspects of clinical trial process: 1) Disease dia...
Sunday, May 03, 2009

Adjustment for multiplicity

›
one of the issues in statistics field is the adjustment for multiplicity - adjustment of alpha level for multiple tests. The multiplicity ca...
3 comments:
Friday, May 01, 2009

Understanding person-year or patient-year

›
When I studied the public health many years ago, in occupational health class, the term 'person year' was pretty often used. Since t...
15 comments:
Saturday, April 25, 2009

Acronym related to Clinical trials in EU countries

›
In order to conduct a clinical trial in the EC, the sponsor must first submit a valid request for authorisation to the Competent Authority o...
1 comment:
Sunday, April 19, 2009

Risk management, pharmacoepidemiology, and pharmacovigilence

›
Risk Management: Risk management is the overall and continuing process of minimizing risks throughout a product's lifecycle to ...
2 comments:
‹
›
Home
View web version

About Me

My photo
Web blog from Dr. Deng
Chapel Hill, NC, United States
邓春勤 A Medical Doctor turned into Biostatistician in Clinical Trial and Drug Development Industry
View my complete profile
Powered by Blogger.